Free beauty treatments and free IPODS and other goodies in prize draws are being offered to young girls if they have the HPV vaccines. However, is it morally correct to coerce youngsters into conforming? At present the HPV vaccination programme is being questioned by many Governments as to it’s safety and some countries have even withdrawn from the programme altogether.
LEADING scientists and doctors have raised fresh concerns about the safety of a cervical cancer vaccine. They have accused the manufacturers of Cervarix and another jab, Gardasil, of making misleading claims. More than 1,300 British girls have reported adverse reactions to Cervarix, ranging from paralysis to convulsions and sight problems.
The medical staff refused to take part because they did not have enough experience with the vaccine and were concerned about possible side effects, a spokesman for youth health services in Brabant told the paper. Doctors’ organization LAD refused to say how many were involved. But a spokesman said it is the first time doctors have registered a formal refusal to vaccinate.
According to the Canadian Women’s Health Network, most women who don’t smoke, eat well and have a healthy immune system will clear the virus without any treatment. And the Public Health Agency of Canada has said that more than 80 per cent of HPV infections acquired at an early age were gone within a year and a half. Even better, after a woman has fought off a strain, she has almost no chance of contracting it again.
HPV is one causal factor in the development of cervical cancer. Medical researchers note other factors contribute to cervical cancer, such as: Poverty— limited or no access to medical services; tobacco use; eating habits; weakened immune system; hormonal medications; exposure to Diethylstilberstrol (DES); Douching; and Chemical exposure in work environment.
What Exactly Is Cervical Cancer? Cancer begins in cells, the building blocks of tissue which make up the organs. Normally, cells grow and divide to form new cells as the body needs them. When cells grow old, they die and are replaced with new cells. The problem comes in when abnormal cells “appear” and start [...]
To date, GlaxoSmithKline’s HPV-vaccine, Cervarix has been approved in 95 countries around the world, including the 27 member states of the European Union (EU), Australia, Brazil, South Korea, Mexico and Taiwan. Licensing applications have been submitted in more than 20 additional countries including Japan and the United States. GSK also submitted the vaccine to the World Health Organization (WHO) for prequalification in September 2007.
JPMorgan pharma analyst Chris Schott wrote in a research note to clients Friday, “The larger issue for cervical cancer vaccines in the US is the relative stagnation of the US market. We forecast a decline in US vaccinations (and thus US market sales) in 2009 relative to 2008, with 2010 sales returning to roughly 2008 levels.”
Touting competing studies, Merck and Glaxo use 25th International Papillomavirus Conference as venue to fight for increased sales for their HPV-vaccines, Gardasil and Cervarix. Glaxo released a new Cervarix vs. Gardasil head-to-head study, saying Cervarix prompted a stronger immune response. Merck has been promoting its own ‘new’ study data, which claims Gardasil offers protection from certain HPV strains for up to 9.5 years. Can trial data make a big difference in revenues for either company? Merck is facing declining sales and Glaxo has yet to gain FDA approval and is dealing with efficacy issues in the U.K.
Girls and women who receive the Gardasil vaccine to prevent cervical cancer may be at increased risk of Guillain-Barre syndrome, a rare but serious disorder of the nervous system, in the first six weeks, especially the first two weeks, after vaccination. The findings were presented at the annual meeting of the American Academy of Neurology.
© 2002- An Inconvenient Woman. Site design and construction by Pleiades Publishing Services, Co.
Powered by Wordpress and based on the template design MyJournal Hypereal by 
BlogoSquare
